Christian B. Dinneen-Long
General Counsel bei GLYCOMIMETICS, INC.
Profil
Christian B.
Dinneen-Long is currently the Secretary, Vice President & Corporate Counsel at GlycoMimetics, Inc. He previously worked as an Assistant General Counsel at Guilford Pharmaceuticals, Inc., an Associate General Counsel at Emergent BioSolutions, Inc., and a Senior Counsel at Medimmune, Inc. He received his undergraduate degree from the University of Wisconsin and his graduate degree from Chicago-Kent College of Law.
Aktive Positionen von Christian B. Dinneen-Long
| Unternehmen | Position | Beginn |
|---|---|---|
| GLYCOMIMETICS, INC. | General Counsel | 29.04.2019 |
Ehemalige bekannte Positionen von Christian B. Dinneen-Long
| Unternehmen | Position | Ende |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | General Counsel | - |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | General Counsel | - |
| Medimmune, Inc. | General Counsel | - |
Ausbildung von Christian B. Dinneen-Long
| University of Wisconsin | Undergraduate Degree |
| Chicago-Kent College of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
| Medimmune, Inc. | Health Technology |
